Why Is Cognizant (CTSH) Down 0.1% Since Last Earnings Report?

Cognizant (CTSH) reported robust Q2 2025 results, with non-GAAP EPS of $1.31, up 12% year-over-year, and revenues of $5.25 billion, up 8.1% year-over-year, both exceeding consensus estimates. This growth was primarily driven by the Belcan acquisition and strong organic performance in Health Sciences and Financial Services, alongside significant new bookings, including two $1 billion mega deals and over 2,500 early Generative AI client engagements. The company provided optimistic Q3 and full-year 2025 guidance, projecting FY25 revenues between $20.7 billion and $21.1 billion and adjusted EPS of $5.08-$5.22, with estimates trending upward. Despite these strong financials and positive outlook, CTSH shares have marginally underperformed the S&P 500 since the earnings release.

Analysis

Cognizant Technology Solutions (CTSH) demonstrated robust fundamental performance in its Q2 2025 earnings report, which appears disconnected from its recent stock price stagnation. The company delivered beats on both the top and bottom lines, with non-GAAP EPS of $1.31 increasing 12% year-over-year and revenues growing 8.1% to $5.25 billion. This growth was fueled by the Belcan acquisition, which added approximately 400 basis points, and organic strength across key segments, most notably in Products and Resources which grew 16% year-over-year. Critically, forward-looking indicators are strong; trailing 12-month bookings increased 6% to $27.8 billion, representing a healthy book-to-bill ratio of 1.4x, and the total contract value of large deals doubled year-over-year. The company also provided strong guidance for FY2025, projecting revenue growth of 4.7%-6.7% and an expansion in adjusted operating margin of 20 to 40 basis points. Despite these positive catalysts and upward-trending analyst estimates, the stock has underperformed the S&P 500 with a 0.1% loss since the report, creating a potential valuation disconnect that contrasts with the positive underlying business momentum and strategic traction in areas like Generative AI, where it has over 2,500 client engagements.

Key Decisions for Investors

• Consider the stock's flat performance post-earnings as a potential opportunity, given the significant disconnect between its price and the strong Q2 results, robust full-year guidance, and upward analyst estimate revisions.
• Monitor the company's ability to convert its strong commercial pipeline, evidenced by a 1.4x book-to-bill ratio and a doubling of large deal contract value, into sustained revenue acceleration in subsequent quarters.
• Weigh the bullish fundamental data against the provided mixed signals, such as the Zacks #3 'Hold' rating and a 'D' score for Growth, which may indicate underlying market concerns or a preference for peers despite Cognizant's strong operational execution.